Related Experiment Video
Updated: Jan 18, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Fighting for every beat: cardiac therapies in Duchenne muscular dystrophy
1Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France. antoine.muchir@inserm.fr.
Insights
Duchenne muscular dystrophy (DMD) causes heart problems due to lack of dystrophin. This review explores new therapies to improve cardiac care for DMD patients.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Neuromuscular Disorders
Background:
- Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by the absence of dystrophin.
- Cardiac complications, including dilated cardiomyopathy and arrhythmias, are a major cause of mortality in DMD patients.
- Degenerative changes in cardiac muscle mirror those in skeletal muscle, leading to heart failure.
Purpose of the Study:
- To review current and emerging therapeutic strategies for cardiac dysfunction in DMD.
- To highlight advancements in managing heart complications associated with Duchenne muscular dystrophy.
- To emphasize the importance of early detection and proactive cardiac care in DMD.
Main Methods:
- This is a review article, synthesizing existing research and clinical findings.
- The review focuses on therapeutic strategies targeting cardiac manifestations of DMD.
- Information was gathered from scientific literature and clinical studies on DMD and cardiac care.
Main Results:
- DMD leads to progressive cardiac muscle degeneration and heart failure.
- Current research is exploring novel therapeutic avenues for DMD cardiac complications.
- Effective management strategies are crucial for improving patient outcomes.
Conclusions:
- Despite no definitive cure for DMD, significant progress is being made in cardiac care.
- Emerging therapies hold promise for transforming treatment and improving quality of life for DMD patients.
- Proactive cardiac management is essential for mitigating morbidity and mortality in Duchenne muscular dystrophy.
Abstract:
Duchenne muscular dystrophy (DMD) is a severe, progressive genetic disorder caused by mutations in the DMD gene, resulting in the absence of dystrophin-a key structural protein at the sarcolemma. As the disease progresses, cardiac involvement becomes a leading cause of morbidity and mortality. By adolescence or early adulthood, many patients develop dilated cardiomyopathy and arrhythmias. Like skeletal muscle, cardiac muscle in DMD patients lacks dystrophin and undergoes similar degenerative changes, ultimately leading to ventricular dilation, systolic dysfunction, and heart failure. Early detection and proactive management of cardiac dysfunction are essential for optimizing outcomes. Despite significant advances and decades of research, a definitive cure for DMD remains elusive. In recognition of World Duchenne Awareness Day, this review highlights current and emerging therapeutic strategies with the potential to transform cardiac care in DMD and improve the lives of those affected.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Satellite Stem Cells and Muscular Dystrophy
Heart Failure Drugs: Inotropic Agents

